In the intensive poultry production and veterinary pharmaceutical sectors, the primary challenge lies in securing high-purity biological materials that ensure vaccine efficacy and diagnostic accuracy. Addressing the biological complexities of poultry parasites requires more than just a supplier; it demands a partnership with a specialized China/Custom coccidiosis or eimeria/coccidia egg/eggs factory capable of delivering consistent, high-titer antigens.
Shijiazhuang Huajun Animal Pharmaceutical Co., Ltd. (ZTHJ Pharma), established in 2008, has emerged as a high-tech cornerstone in this niche. By integrating advanced R&D with a 21,000 square meter state-of-the-art facility in Xinle City, we provide the precision required for specific antigen production. Our 2022 GMP certification from the Ministry of Agriculture underscores our commitment to pharmaceutical-grade environments, ensuring that every batch of eimeria or coccidia-related product meets the rigorous demands of global researchers and pharmaceutical manufacturers.
Technical excellence in the cultivation and processing of parasitic antigens is defined by the sterility of the environment and the genetic stability of the strains. As a leading China/Custom coccidiosis or eimeria/coccidia egg/eggs factory, we utilize multiple specialized production lines—including powders, premixes, and oral solutions—to support the downstream application of our biological raw materials.
| Performance Metric | Industry Significance | Our Engineering Standard | Advantage |
|---|---|---|---|
| Facility Compliance | Ensures non-contamination | 2022 Ministry of Agriculture GMP | Eliminates cross-pathogen risks |
| Antigen Customization | Targeted immunity profiles | R&D Integrated Peptide Synthesis | High specificity for local strains |
| Production Scale | Supply chain stability | 21,000 sqm dedicated site | Supports bulk international demand |
| Product Diversity | Comprehensive treatment | 100+ Pharmaceutical Varieties | One-stop shop for antiparasitics |
The financial viability of livestock operations often hinges on the prevention of sub-clinical coccidiosis, which can silently erode feed conversion ratios. By partnering with a vertically integrated China/Custom coccidiosis or eimeria/coccidia egg/eggs factory, organizations can significantly reduce the "cost-of-quality" associated with inconsistent antigen supplies.
ZTHJ Pharma leverages its strategic location in the Xinle City East Industrial Park and its massive 21,000 sqm footprint to drive economies of scale. Our global reach—facilitated by a multi-language platform spanning Arabic, Russian, German, and Spanish—allows us to export high-value biological solutions that enhance animal health and maximize return on investment for large-scale integrators and local distributors alike.
Related products
Top Selling Products
